Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Asahi Kasei lands approval for new HSV treatment

Japanese pharma Asahi Kasei Therapeutics has snagged FDA approval for a herpes treatment that it acquired early this year in an almost $1 billion deal. The late Friday approval of Hovilpri ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 12 October →